[Clinical and laboratory evaluation of the preparation Synapause].
D000328:Adult; D001798:Blood Proteins / Q000037:antagonists & inhibitors; D002979:Climacteric / Q000187:drug effects*; D045166:Estradiol Congeners / Q000627:therapeutic use / Q000633:toxicity; D004964:Estriol / Q000031:analogs & derivatives* / Q000627:therapeutic use / Q000633:toxicity; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents; D007019:Hypoproteinemia / Q000139:chemically induced; D008055:Lipids / Q000097:blood; D008593:Menopause / Q000187:drug effects*; D008875:Middle Aged
D001798:Blood Proteins; D045166:Estradiol Congeners; D000960:Hypolipidemic Agents; D008055:Lipids; C009341:estriol succinate; D004964:Estriol
Ocena kliniczna i laboratoryjna preparatu Synapause.